Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Melanoma Research|April 1, 1993
Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trialD B Thomson, M Adena, G R McLeod, et al.
British Journal of Cancer|September 30, 2010
Pooled analysis of recent studies on magnetic fields and childhood leukaemiaL Kheifets, A Ahlbom, C M Crespi, et al.
Cancer Treatment Reports|December 1, 1987
Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patientsR M Lowenthal, C N Chesterman, J D Griffiths, et al.
Bone Marrow Transplantation|November 25, 1998
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experienceR M Lowenthal, C Fabères, G Marit, et al.
Animal : an International Journal of Animal Bioscience|June 7, 2021
Quantifying the frequency and volume of urine deposition by grazing sheep using tri-axial accelerometersK A Marsden, L Lush, J A Holmberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumabN C Tebbutt, F Murphy, D Zannino, et al.
Blood|March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemiaJ F Bishop, J P Matthews, G A Young, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.
British Journal of Haematology|June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemiaJ P Matthews, J F Bishop, G A Young, et al.
Pageof 8